As I said, we see the importance of distinguishing between what population-based screening programs do and a differentiated pathway for people who have an elevated and high risk. We hear from patients, and we've done a lot of work surveying patient groups. People are showing up at their family doctors with signs and symptoms and are being refused screening access within this group. If you have, for example, a family history, your risk pathway needs to look different from that of someone who is asymptomatic or not presenting signs and symptoms.
To go back to the mixed messaging point, we see different provinces and territories with different approaches to high-risk guidelines. Again, that creates an inequity of access from province to province. We need leadership in this country to ensure that all Canadians, whether of average risk, high risk or elevated risk, are getting a consistent approach to screening, regardless of where they live in Canada.